Mark Rummel, MD
Vascular Surgery · Kalamazoo, MINPI 1285698134
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,385 of the $9,347 with a category attached, or 79.0%. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 167 payments — averaging $55.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Inari Medical, Inc.$1K
- Silk Road Medical, Inc.$1K
- Medtronic$1K
- Cook Medical LLC$964
- W. L. Gore & Associates, Inc.$892
- plus $3K from 28 others
What the payments were for
- Travel & lodging$1,76119%
- Food & beverage$7,38579%
- Education$2012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $1,281 |
| Inari Medical, Inc. | 15 | $1,219 |
| Silk Road Medical, Inc. | 6 | $1,069 |
| Medtronic(2 entities) | 11 | $1,045 |
| Cook Medical LLC | 16 | $964 |
| W. L. Gore & Associates, Inc. | 24 | $892 |
| Cardiva Medical, Inc. | 7 | $430 |
| Philips North America LLC | 7 | $337 |
| Cardiovascular Systems Inc. | 4 | $298 |
| Johnson & Johnson(2 entities) | 14 | $270 |
| Tactile Systems Technology Inc | 7 | $238 |
| Bard Peripheral Vascular, Inc. | 4 | $179 |
| Organogenesis Inc. | 2 | $152 |
| Kerecis Limited | 4 | $145 |
| Lemaitre Vascular, Inc. | 4 | $116 |
| Penumbra, Inc. | 2 | $95 |
| Mozarc Medical US LLC | 2 | $65 |
| Boston Scientific | 2 | $63 |
| Terumo Medical Corporation | 3 | $59 |
| Reflow Medical Inc | 3 | $57 |
| Cashflow Solutions, LLC | 3 | $50 |
| Integra Lifesciences Corporation | 1 | $50 |
| Bioventus LLC | 1 | $44 |
| Angiodynamics, Inc. | 2 | $30 |
| Cordis US CORP. | 1 | $28 |
| Novo Nordisk | 1 | $28 |
| Convatec Inc. | 1 | $27 |
| Smith+Nephew | 1 | $21 |
| Abbott | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Sanara Medtech Inc. | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,109
- FLOWTRIEVER CATHETER, S$1,444
- CT THROMBECTOMY SYSTEM KIT$1,444
- ENROUTE Transcarotid Stent$1,055
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,055
- DIVERGENCE-L$725
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$231
- GORE TAG Conformable Thoracic Endoprosthesis$192
- VENACORE THROMBECTOMY CATHETER$173
- GORE EXCLUDER AAA Endoprosthesis$155
- Peripheral Orbital Atherectomy System$141
- Cook Medical Zilver PTX$125
- SIMPLIMAX$124
- Zenith Spiral-Z$116
- Cook$108
- CLOTTRIEVER BOLD CATHETER$105
- Cardiva VASCADE 6/7F VCS$105
- Diamondback Peripheral$100
How this compares
$9,347 in reported general payments places this provider in the 75th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $13,938 |
| ClopidogrelClopidogrel Bisulfate | 31 | $555 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $270 | $13,93819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Kalamazoo
- Daniel JohnstonKalamazoo$21K
- William RangerKalamazoo$13K
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
- Eanas YassaGrand Rapids$81K
- Abedelkarim AbushmaiesBattle Creek$75K
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.